Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 23255598)

1.

Hypoxia-inducible factor 1α regulates a SOCS3-STAT3-adiponectin signal transduction pathway in adipocytes.

Jiang C, Kim JH, Li F, Qu A, Gavrilova O, Shah YM, Gonzalez FJ.

J Biol Chem. 2013 Feb 8;288(6):3844-57. doi: 10.1074/jbc.M112.426338. Epub 2012 Dec 19.

2.

Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.

Kanatani Y, Usui I, Ishizuka K, Bukhari A, Fujisaka S, Urakaze M, Haruta T, Kishimoto T, Naka T, Kobayashi M.

Diabetes. 2007 Mar;56(3):795-803.

3.

Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice.

Jiang C, Qu A, Matsubara T, Chanturiya T, Jou W, Gavrilova O, Shah YM, Gonzalez FJ.

Diabetes. 2011 Oct;60(10):2484-95. doi: 10.2337/db11-0174. Epub 2011 Aug 26.

4.

Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.

Serrano-Marco L, Rodríguez-Calvo R, El Kochairi I, Palomer X, Michalik L, Wahli W, Vázquez-Carrera M.

Diabetes. 2011 Jul;60(7):1990-9. doi: 10.2337/db10-0704. Epub 2011 May 26.

5.

Basic fibroblast growth factor regulates glucose metabolism through glucose transporter 1 induced by hypoxia-inducible factor-1α in adipocytes.

Kihira Y, Yamano N, Izawa-Ishizawa Y, Ishizawa K, Ikeda Y, Tsuchiya K, Tamaki T, Tomita S.

Int J Biochem Cell Biol. 2011 Nov;43(11):1602-11. doi: 10.1016/j.biocel.2011.07.009. Epub 2011 Jul 26.

PMID:
21810481
6.

Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes.

Ishizuka K, Usui I, Kanatani Y, Bukhari A, He J, Fujisaka S, Yamazaki Y, Suzuki H, Hiratani K, Ishiki M, Iwata M, Urakaze M, Haruta T, Kobayashi M.

Endocrinology. 2007 Jun;148(6):2994-3003. Epub 2007 Mar 22.

PMID:
17379643
7.

Long-term interleukin-1alpha treatment inhibits insulin signaling via IL-6 production and SOCS3 expression in 3T3-L1 adipocytes.

Uno T, He J, Usui I, Kanatani Y, Bukhari A, Fujisaka S, Yamazaki Y, Suzuki H, Iwata M, Ishiki M, Urakaze M, Haruta T, Ogawa H, Kobayashi M.

Horm Metab Res. 2008 Jan;40(1):8-12. Epub 2007 Dec 17.

PMID:
18085494
8.

Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.

Wada T, Hoshino M, Kimura Y, Ojima M, Nakano T, Koya D, Tsuneki H, Sasaoka T.

Am J Physiol Endocrinol Metab. 2011 Jun;300(6):E1112-23. doi: 10.1152/ajpendo.00370.2010. Epub 2011 Mar 8.

9.

Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes.

Chen B, Lam KS, Wang Y, Wu D, Lam MC, Shen J, Wong L, Hoo RL, Zhang J, Xu A.

Biochem Biophys Res Commun. 2006 Mar 10;341(2):549-56. Epub 2006 Jan 13.

PMID:
16427606
10.

Adipose tissue-specific inhibition of hypoxia-inducible factor 1{alpha} induces obesity and glucose intolerance by impeding energy expenditure in mice.

Zhang X, Lam KS, Ye H, Chung SK, Zhou M, Wang Y, Xu A.

J Biol Chem. 2010 Oct 22;285(43):32869-77. doi: 10.1074/jbc.M110.135509. Epub 2010 Aug 16.

11.

Increased GIP signaling induces adipose inflammation via a HIF-1α-dependent pathway and impairs insulin sensitivity in mice.

Chen S, Okahara F, Osaki N, Shimotoyodome A.

Am J Physiol Endocrinol Metab. 2015 Mar 1;308(5):E414-25. doi: 10.1152/ajpendo.00418.2014. Epub 2014 Dec 23.

PMID:
25537494
12.

PCBP2 regulates hepatic insulin sensitivity via HIF-1α and STAT3 pathway in HepG2 cells.

Xia N, Tang Z, Wang C, Xu G, Nie X, Zhang W, Zhao Y, Wang S, Zhu X, Cui S.

Biochem Biophys Res Commun. 2015 Jul 17-24;463(1-2):116-22. doi: 10.1016/j.bbrc.2015.04.150. Epub 2015 May 19.

PMID:
26002461
13.

Midkine, a potential link between obesity and insulin resistance.

Fan N, Sun H, Wang Y, Zhang L, Xia Z, Peng L, Hou Y, Shen W, Liu R, Peng Y.

PLoS One. 2014 Feb 7;9(2):e88299. doi: 10.1371/journal.pone.0088299. eCollection 2014.

14.

Conditioned medium from hypoxia-treated adipocytes renders muscle cells insulin resistant.

Yu J, Shi L, Wang H, Bilan PJ, Yao Z, Samaan MC, He Q, Klip A, Niu W.

Eur J Cell Biol. 2011 Dec;90(12):1000-15. doi: 10.1016/j.ejcb.2011.06.004. Epub 2011 Oct 1.

PMID:
21962636
15.

Visfatin in adipocytes is upregulated by hypoxia through HIF1alpha-dependent mechanism.

Segawa K, Fukuhara A, Hosogai N, Morita K, Okuno Y, Tanaka M, Nakagawa Y, Kihara S, Funahashi T, Komuro R, Matsuda M, Shimomura I.

Biochem Biophys Res Commun. 2006 Oct 27;349(3):875-82. Epub 2006 Jul 28.

PMID:
16970912
16.

Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling.

Clementi AH, Gaudy AM, van Rooijen N, Pierce RH, Mooney RA.

Biochim Biophys Acta. 2009 Nov;1792(11):1062-72. doi: 10.1016/j.bbadis.2009.08.007. Epub 2009 Aug 20.

17.

Adiponectin deficiency impairs liver regeneration through attenuating STAT3 phosphorylation in mice.

Shu RZ, Zhang F, Wang F, Feng DC, Li XH, Ren WH, Wu XL, Yang X, Liao XD, Huang L, Wang ZG.

Lab Invest. 2009 Sep;89(9):1043-52. doi: 10.1038/labinvest.2009.63. Epub 2009 Jun 29.

18.

Deletion of hypoxia-inducible factor-1α in adipocytes enhances glucagon-like peptide-1 secretion and reduces adipose tissue inflammation.

Kihira Y, Miyake M, Hirata M, Hoshina Y, Kato K, Shirakawa H, Sakaue H, Yamano N, Izawa-Ishizawa Y, Ishizawa K, Ikeda Y, Tsuchiya K, Tamaki T, Tomita S.

PLoS One. 2014 Apr 4;9(4):e93856. doi: 10.1371/journal.pone.0093856. eCollection 2014.

19.

Brd2 disruption in mice causes severe obesity without Type 2 diabetes.

Wang F, Liu H, Blanton WP, Belkina A, Lebrasseur NK, Denis GV.

Biochem J. 2009 Dec 14;425(1):71-83. doi: 10.1042/BJ20090928.

20.

A novel IKKbeta inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance.

Kamon J, Yamauchi T, Muto S, Takekawa S, Ito Y, Hada Y, Ogawa W, Itai A, Kasuga M, Tobe K, Kadowaki T.

Biochem Biophys Res Commun. 2004 Oct 8;323(1):242-8.

PMID:
15351728
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk